covid-19 pandemic impact is driving the Cell Surface Markers Market

Latest News:- Cell Surface Markers Market: Disease diagnosis is expected to lead the Application segment during 2024-2028

Technavio analyzes that the Cell Surface Markers Market is expected to grow at a CAGR of 8.25% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 14.07 billion.There are various factors that contribute to the growth of the market. The COVID-19 pandemic has significantly impacted the Cell Surface Markers Market. With the disruption of research and development activities, there has been a delay in the launch of new products. Additionally, the healthcare sector's focus on COVID-19 treatment and diagnostics has led to a decrease in demand for cell surface markers in non-COVID-19 applications. However, the market is expected to recover as research activities resume and the demand for cell surface markers in COVID-19 research and diagnostics increases. Despite the challenges, companies are investing in digitalization and automation to streamline their operations and maintain competitiveness.

Cell surface markers, also known as cell surface proteins, play a pivotal role in the identification and classification of various cells in the fields of hematology and immunology. These markers are utilized extensively in immunophenotyping, a technique that facilitates efficient disease identification, sample preparation, and research applications, including drug discovery and disease diagnosis. Hematology analyzers, reagents, and kits, as well as flow cytometry systems, are integral tools for the analysis of cell surface markers. The growing adoption of in-vitro diagnostics (IVD) in the healthcare industry, driven by the increasing incidence of chronic diseases such as cancer and autoimmune disorders, as well as the need for high-speed, multiparametric analysis, is expected to fuel market growth. IVDs, which encompass diagnostic test products, instruments, and supplies, enable accurate and rapid identification of conditions outside the body, thereby reducing the time to diagnosis and subsequent treatment determination in various clinical and pharmaceutical applications. 

Know which region is leading the market growth by requesting a sample report

Cell Surface Markers Market Segmentation

• Application
  • Disease diagnosis
  • Research
  • drug discovery
• Product
  • Antibody
  • PCR array
• Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

• Abbott Laboratories
• Abcam plc
• Agilent Technologies Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• Bio Techne Corp.
• Cell Signaling Technology Inc.
• Danaher Corp.
• DiaSorin SpA
• F. Hoffmann La Roche Ltd.
• GenScript Biotech Corp.
• Grifols SA
• IVD Medical Holding Ltd.
• Johnson and Johnson
• PerkinElmer Inc.
• QIAGEN NV
• Siemens Healthineers AG
• Sysmex Corp.
• Thermo Fisher Scientific Inc.
• Werfenlife SA

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

Cell surface markers, also known as cell surface antigens or CD markers, are proteins and molecules that function as identification tags on the surface of cells. In medical research, they play a crucial role in various applications, including diagnostics, drug development, and life sciences research. The prevalence of diseases such as cancer, inflammatory conditions, and host-pathogen interactions have increased the demand for these markers in research and in vitro diagnostics. Life Sciences Solutions and laboratories utilize antibodies to identify and study these markers in mice, rats, and other organisms. Funding from both public and private sectors continues to drive innovation and advancements in this field.

Market Research Overview

The Cell Surface Markers Market is a significant segment of the global Life Sciences Tools and Services Market. This market caters to medical research, diagnostics, and drug development sectors by providing essential identification tags for specific cell types and populations through cell surface antigens, proteins, and molecules. Technavio, a leading market research firm, includes this market in its comprehensive analysis of the global Life Sciences Tools and Services Market. This market encompasses manufacturers of equipment, supplies, and services for research and development in pharmaceuticals and biotechnology, as well as laboratory diagnosis of various diseases. Key applications include disease mechanism understanding and therapeutic targeting. The market size is determined by the combined revenue generated by these entities.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

• Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.


• Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.


• High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/